Merck flags decline in operating profit of up to 10 percent in 2023 Ruchika Sharma14 May 2023 6:00 AM GMTGermany: Germany's Merck KGaA on Thursday warned that adjusted operating earnings could decline by as much as 10% this year as the outlook for...
Merck appoints Helene von Roeder as new CFO Ruchika Sharma9 May 2023 11:00 AM GMTDarmstadt: Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June 30, 2023. He...
Merck beats first-quarter expectations on Keytruda, Gardasil strength Ruchika Sharma30 April 2023 10:30 AM GMTBengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...
USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug Ruchika Sharma29 April 2023 7:00 AM GMTLynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.
Merck-Moderna vaccine helps keep patients free from skin cancer Roshni Dhar17 April 2023 12:30 PM GMTAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by...
Health Bulletin 17/April/2023 Roshni Dhar17 April 2023 10:59 AM GMTHere are the top health stories for the day:NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroadThe NEET exam conducting body...
Merck to acquire Prometheus Biosciences for USD 11 billion Ruchika Sharma17 April 2023 7:00 AM GMTRahway: Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. have announced that the companies have entered into...
USFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: Merck Ruchika Sharma15 April 2023 5:49 AM GMTThe company must now place on hold the initiation of new evobrutinib patients and halt studies involving patients who have been taking the drug for...
USFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Ruchika Sharma14 April 2023 5:30 AM GMTKEYTRUDA is an anti-programmed death receptor-1 therapy that works by increasing the ability of the body's immune system to help detect and fight...
Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma Ruchika Sharma9 April 2023 9:00 AM GMTMelanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.
Setback: Merck, Eisai to stop late-stage study of Keytruda plus Lenvima for metastatic melanoma Ruchika Sharma8 April 2023 8:31 AM GMTThey also said another late-stage trial for Keytruda and Lenvima did not meet its main goal of overall survival for treating a type of colorectal or...
Merck gets USFDA nod for Keytruda in combination with Padcev to treat Advanced or Metastatic Urothelial Cancer Ruchika Sharma5 April 2023 7:46 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
